Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Medical Ethics|December 9, 2025
Caution before condemnation: rethinking responsibility for Gaza's healthcare scarcitySimon LucasThe Journal of Organic Chemistry|March 11, 2006
Syntheses and synthetic applications of stannylated allylic alcoholsUli Kazmaier, Simon Lucas, Manuela KleinActa Biotheoretica|August 29, 2024
The Effects of Triiodothyronine on the Free Thyroxine Set Point Position in the Hypothalamus Pituitary Thyroid AxisSimon Lucas Goede, Melvin Khee Shing LeowBioethics|November 6, 2023
How moral bioenhancement affects perceived praiseworthinessSimon Lucas, Thomas Douglas, Nadira S FaberNeurochemical Research|February 22, 2014
Inhibition of AMPA receptors by polyamine toxins is regulated by agonist efficacy and stargazinMette H Poulsen, Simon Lucas, Kristian Strømgaard, et al.Molecular Pharmacology|November 14, 2013
Evaluation of PhTX-74 as subtype-selective inhibitor of GluA2-containing AMPA receptorsMette H Poulsen, Simon Lucas, Kristian Strømgaard, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 12, 2009
Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivoChristina Ries, Simon Lucas, Ralf Heim, et al.Journal of Medicinal Chemistry|March 10, 2011
Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivativesSimon Lucas, Matthias Negri, Ralf Heim, et al.Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.Pageof 3